Matches in Nanopublications for { <http://bio2rdf.org/drugbank_resource:DB00530_DB00582> ?p ?o ?g. }
Showing items 1 to 4 of
4
with 100 items per page.
- drugbank_resource:DB00530_DB00582 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00530_DB00582 label "DDI between Erlotinib and Voriconazole - Voriconazole, a strong CYP3A4 inhibitor, may increase the serum concentration of erlotinib by decreasing its metabolism. Monitor for changes in the therapeutic and adverse effects of erlotinib if voriconazole is initiated, discontinued or dose changed. [drugbank_resource:DB00530_DB00582]" assertion.
- drugbank_resource:DB00530_DB00582 identifier "drugbank_resource:DB00530_DB00582" assertion.
- drugbank_resource:DB00530_DB00582 title "DDI between Erlotinib and Voriconazole - Voriconazole, a strong CYP3A4 inhibitor, may increase the serum concentration of erlotinib by decreasing its metabolism. Monitor for changes in the therapeutic and adverse effects of erlotinib if voriconazole is initiated, discontinued or dose changed." assertion.